Allergan BIOCELL Breast Implants and BIA-ALCL: What Patients Need to Know

If you’ve had Allergan BIOCELL textured breast implants, you may have seen recent headlines about lawsuits in the United States. Understandably, this can feel confusing or worrying. Here’s a clear breakdown of what’s happening, why it matters, and what it could mean for patients in the UK.

What’s going on in the U.S?

In America, thousands of women have brought lawsuits against Allergan. The cases focus on the reported link between Allergan’s BIOCELL textured breast implants and a rare cancer called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL).

Right now, around 1,460 lawsuits are active in the U.S. These cases have been grouped together in what’s known as a multidistrict litigation (MDL) in New Jersey. This system helps courts deal with large numbers of similar cases more efficiently.

Some important updates:

• The court has scheduled regular conferences throughout 2026 to keep the cases moving forward.
• Both sides are meeting with a judge in October 2025 to see if any settlements can be reached before trial.
• The first “bellwether” trial – a kind of test case that helps set the tone for other lawsuits – is due to start in June 2026.
• The outcomes of these U.S. trials could influence how claims are handled in other countries, including the UK.
• A further update outlines how investigations are progressing in Europe, specifically in the Netherlands

What about the UK?

Here in the UK, there’s also growing concern about textured implants and BIA-ALCL. Regulators have issued safety alerts, and lawyers are exploring possible legal claims on behalf of patients.

The UK doesn’t have the same type of class action system as the U.S. Instead, groups of people with similar claims can bring a case together through something called a Group Litigation Order (GLO).

At the moment, no official group case has started against Allergan in the UK – but that could change if enough women come forward. Law firms (including Fletchers Solicitors) are actively investigating potential claims.

What should patients do?

If you have (or previously had) Allergan BIOCELL textured breast implants, here are a few steps you might consider:

• Stay informed: Keep an eye on updates from regulators such as the MHRA (Medicines and Healthcare products Regulatory Agency).
• Check in with your doctor: If you have symptoms or concerns, speak to your GP or surgeon promptly.
• Explore your options: If you’ve experienced complications, you may have legal rights. Speaking to a specialist solicitor can help you understand whether you might be able to join a claim.

Final thoughts

The U.S. litigation is moving into an important phase, with the first trials scheduled for 2026. While the situation in the UK is different, patients here should know that legal options may become available.

If you’re concerned about Allergan implants and want to know more about your rights, you can read further on our dedicated group action page.